Historically, kidney care has meant focusing on people who need dialysis, and companies have tried to offer this very expensive treatment to patients with kidney failure and near-end-stage renal disease.
This is where the system goes completely wrong, believing that the executives of a new company want to change the minds of kidney care. new entity – Interwell Health – launched, launched on Monday By merging three companies – InterWell, Fresenius Health Partners and Cricket Health.
“About 600,000 Americans are on dialysis. But there are 36 million Americans who had kidney disease before kidney failure, and as (these) patients progress to kidney failure, they receive little attention,” said Robert Sepcha, Chief Executive Officer Cricket Health Interview Wednesday.
What the combination of Cricket, InterWell and Fresenius Health Partners has done is recognize the whole journey, Sepucha said.
InterWell focuses on providing value-based care for patients with advanced chronic kidney disease.The combined company is valued at $2.4 billion a total addressable market $170 billion and Exceed $6 billion Managed medical expenses, calculated by multiplying by the number of members included in a value-based reimbursement plan.The company said that by 2025 it expects to participate in and manage the care of more than 270,000 Americans with kidney disease and increase the cost of healthcare it manages to $11 billion.
Given that Fresenius Medical Care is one of the major players in the dialysis market, the move to create a new company to study kidney disease early in the continuum is significant.
“This merger will enable us to Kidney care,” Fresenius Medical Care Delivery CEO Bill Valle said in an email.
even DavitaAnother big name in dialysis care, has been emphasizing the need to move from quantitative care to value-based care. Patient-centered care improvements include not only making dialysis more convenient by providing dialysis at home, but also providing a whole-person care model that educates patients on disease management and lifestyle changes.
And doing it all well may require introducing different capabilities, which on paper the InterWell merger appears to possess.
InterWell Health brings a network of more than 1,600 nephrologists and Fresenius Health Partners – the value-based care division Fresenius Medical Care North America—Add its expertise in value-based kidney care contracts to the combined company. At the same time, Cricket Health integrates technology platforms and analytics capabilities.
“arrive To have a real impact on improving patient outcomes and improving their quality of life, while delivering better cost outcomes for our payment partners, you need to address all diseases,” Sepucha said.
Cricket has been doing this by identifying patients earlier and giving them the support and resources they need Not only to understand their disease, but to take a more active role in their own care, Sepucha said.As a result, the company Has been able to improve patient outcomes and reduce patient care costs Commercial insurance is the same as Medicare Advantage, he said.
It is believed that Sepucha and Fresenius combining the capabilities of San Francisco-based Cricket with those of InterWell and Fresenius will improve patients’ quality of life in a number of ways. George Hart, co-chief medical officer of InterWell Health, based in Washam, Massachusetts.This can be done by Fewer hospitalizations and readmissions, slower disease progression, increased transplant referral and transplant rates, Accelerate the transition to home dialysis to improve health equity.
The holy grail, Sepucha and Hart say, is to delay the onset of kidney failure.
“Nephrologists now often find themselves left untouched in an otherwise very fragmented health care delivery system,” Hart said. “We are trying to care for these patients with these serious diseases. They are very vulnerable and often socioeconomically disadvantaged.”
While a single healthcare provider can only do so much, the combined company brings together tools like Cricket’s predictive analytics to better predict patient care needs and human resources.Ultimately, this will improve Patient education and support, such as social workers, nutritionists and nurses, to help them navigate the process, Hart said.
The goal is to provide The extraordinary care and excellent disease management patients deserve, he said, Include slow the progression of chronic kidney disease, or in some cases, stop CKD before it started. New company will expand support doctors need to elevate their way By closely aligning workflows and providing data, education and The care management resources necessary to succeed in a value-based world, Hart said.
Photo: Haywards, Getty Images
